VT-401 (Visus Therapeutics/Cella Therapeutics)

N/A

Report date: 2025/01/26 17:34:05
NME

Base Information

Drug NameVT-401 (Visus Therapeutics/Cella Therapeutics)
Drug Alias NameGlaucoma Therapeutic (Visus Therapeutics/Cella Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCella Therapeutics LLC
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A